Curaleaf stocks up 3.3% after announcing deal with CVS
August 22, 2019
|In Cannabis
CVS and Curaleaf have struck a deal that allows Curaleaf to sell their CBD products at select CVS locations around the US. CVS currently sells CBD products in 8 states including Alabama, California, Colorado, Illinois, Indiana, Kentucky, Maryland and Tennessee. Curaleaf stocks rose 3.3% with the announcement of the deal.
Related Posts
Cannabis Popularity Soars Along With Tests To Detect It
The Duquenois Levine Test is used in the field by law enforcement officers to test for THC presence in a suspected sample. The problem with…
Hound Labs, Cannabix and Vox Heat Up the Marijuana Breathalyzer Market
At the start of April 2021, Patent Forecast® released an insight going over some of the big name competitors getting their foot in the door…
Driving While High? Cannabis Sobriety Testing Heats Up
What’s the future of cannabis innovation? We see things before they happen using our Patent Forecast®. One of those is the development of…